Skip to main content
Premium Trial:

Request an Annual Quote

Lion, MDL in Software Licensing, Distribution Deal

NEW YORK, July 19 – Lion Bioscience said Thursday it would license software from MDL Information Systems, a developer of chemistry-based software, in order develop new applications that could then be integrated with MDL’s products.

The deal is designed to help Lion of Heidelberg, Germany to offer products across the entire life science research and development process. 

The license includes MDL's ISIS, Assay Explorer, Apex, Afferent, and CrossFire Beilstein. Lion will also use these tools within its internal drug discovery unit.

In exchange, MDL of San Leandro, Calif., has been granted a license to be the exclusive reseller for Lion’s idea product line for the prediction and analysis of ADME (adsorption, distribution, metabolism, excretion).

Financial details of the agreements were not disclosed. 

In April, Lion hired three executives from MDL, including Rudolph Potenzone, who is now president and CEO of Lion's US operations, Daniel Keesman, who is vice president of global sales and marketing, and Mark Canales who is senior vice president of cheminformatics development.   

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.